7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-06-30 2004-03-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 
      
    		                                                                                           
      assets
    		                                                                                           
      current assets:
    		                                                                                           
      cash and cash equivalents
    		139,376,000 67,669,000 47,989,000 72,307,000 63,619,000 18,139,000 50,093,000 22,954,000 19,275,000 28,445,000 88,728,000 45,006,000 4,116,000 5,280,000 14,993,000 19,522,000 23,430,000 21,863,000 31,853,000 47,619,000 456,916,000 115,156,000 117,527,000 71,543,000 225,302,000 273,047,000 105,113,000 117,164,000 115,560,000 151,459,000 51,024,000 20,620,000 32,739,000 60,223,000 10,641,000 18,752,000 86,580,000 61,350,000 31,293,000 97,428,000 93,770,000 108,238,000 165,766,000 160,203,000 180,663,000 14,537,000 12,977,000 11,639,000 3,271,000 5,923,000 5,037,000 12,381,000 7,046,000 8,885,000 9,777,000 7,041,000 2,251,000 3,441,000 6,033,000 3,346,000 3,796,000 3,235,000 4,044,000 16,032,000 5,160,000 3,549,000 4,920,000 28,753,000 11,801,000 29,177,000 59,543,000 76,812,000 69,301,000 103,611,000 403,911,000 158,401,000 10,029,000 41,615,000 49,808,000 66,756,000 49,588,000 32,580,000 50,956,000 92,310,000 41,920,000 65,558,000 73,002,000 24,248,000 12,979,000 42,423,000 23,177,000 
      short-term investments
    		525,146,000 177,351,000 160,912,000 183,858,000 156,024,000 208,793,000 260,500,000 147,355,000 171,227,000 190,596,000 193,937,000 166,864,000 117,291,000 142,655,000 189,006,000 321,586,000 299,781,000 279,972,000 307,354,000 363,567,000 338,154,000 694,724,000 621,284,000 939,989,000 874,383,000 1,059,002,000 1,323,575,000 601,217,000 891,128,000 805,468,000 213,329,000 181,041,000 169,520,000 112,404,000 148,733,000 122,296,000 37,535,000 45,603,000 81,908,000 102,791,000 93,528,000 73,371,000 11,459,000 7,133,000 5,925,000 7,490,000 12,275,000 4,340,000      1,500,000 1,517,000 10,000,000 10,000,000 10,000,000 10,487,000 19,351,000 20,273,000 28,960,000 35,012,000 37,200,000 39,033,000 51,961,000 47,684,000 51,918,000 59,311,000 55,819,000 30,685,000 17,596,000 29,091,000 11,789,000 6,319,000 13,447,000 21,862,000 19,168,000 17,897,000 20,174,000 24,202,000 35,694,000 38,449,000        12,099,000 
      accounts receivable
    		57,560,000 41,288,000 38,492,000 38,376,000 34,318,000 37,481,000 28,435,000 32,917,000 36,003,000 27,994,000 29,188,000 30,424,000 65,168,000 62,308,000 41,797,000 85,453,000 64,336,000 58,156,000 54,436,000 56,847,000 32,907,000 41,874,000 39,506,000 30,387,000 21,958,000 20,259,000 26,615,000 55,850,000 46,976,000 42,001,000 37,108,000 25,596,000 12,816,000 13,462,000 7,057,000 14,700,000 6,586,000 9,966,000 11,779,000 6,170,000 5,517,000 5,532,000 7,423,000 12,634,000 5,812,000 3,133,000 4,673,000 2,222,000 5,507,000 699,000 4,622,000 4,589,000 2,157,000 817,000 1,992,000 6,110,000 1,719,000 1,038,000 1,383,000 993,000 96,000  298,000 618,000 2,110,000 1,050,000 2,715,000      14,000 50,000 1,269,000 11,521,000 7,077,000 18,667,000 20,046,000 20,954,000 24,378,000 21,016,000 18,324,000 30,847,000 17,936,000 14,185,000 9,923,000 7,689,000 17,086,000 7,356,000 7,001,000 
      inventory
    		11,900,000 15,489,000 14,614,000 14,114,000 16,740,000 18,672,000 21,337,000 23,969,000 25,392,000 26,906,000 14,011,000 13,294,000 22,326,000 24,773,000 25,614,000 27,326,000 32,996,000 39,946,000 36,932,000 26,487,000 13,430,000 3,702,000 7,320,000 7,296,000 6,565,000 9,638,000 11,905,000 7,124,000 8,136,000 9,520,000 10,531,000 4,373,000 5,007,000 6,809,000 7,629,000 1,923,000 4,027,000 3,835,000 1,750,000 1,633,000 1,221,000 802,000 2,821,000 269,000 1,071,000 817,000 1,949,000 1,392,000 1,838,000 2,265,000 2,838,000 1,697,000 2,548,000 2,698,000 1,345,000 1,301,000 1,960,000 2,594,000 4,212,000                                 
      short-term portion of financial royalty assets
    		12,416,000 10,276,000                                                                                          
      income taxes receivable
    		536,000 828,000 4,339,000 4,073,000 7,813,000   6,395,000    4,614,000 785,000 964,000  6,193,000 6,378,000 4,694,000 1,145,000 2,217,000  2,679,000 7,271,000 11,361,000                                                                    
      other current assets
    		6,986,000 4,816,000 13,285,000 16,897,000 19,741,000 7,122,000 7,311,000 2,657,000 2,097,000 2,770,000 2,331,000 3,399,000 10,746,000 7,804,000 4,656,000 4,671,000 5,161,000 6,270,000 5,708,000 3,822,000 3,191,000 5,489,000 4,940,000 4,734,000 5,039,000 5,672,000 9,228,000 20,418,000 25,339,000 12,817,000 5,647,000 1,514,000 1,112,000 1,072,000 641,000 2,175,000 2,756,000 2,602,000 1,562,000 1,908,000 1,777,000 1,801,000 926,000 1,520,000 1,602,000 1,123,000 841,000 959,000 1,512,000 1,211,000 986,000 829,000 1,015,000 2,025,000 2,778,000 1,344,000 1,663,000 1,868,000 1,151,000 720,000 1,342,000 1,430,000 1,317,000 1,364,000 1,667,000 1,392,000 1,179,000 2,300,000 4,029,000 2,434,000 3,020,000 5,068,000 2,629,000 2,771,000 4,567,000 9,518,000 12,465,000 25,986,000 16,357,000 15,750,000 12,672,000 12,924,000 17,076,000 17,713,000 3,245,000 3,764,000 3,188,000 2,635,000 6,547,000 7,308,000 2,835,000 
      total current assets
    		753,920,000 352,945,000 309,316,000 331,559,000 309,388,000 312,259,000 368,913,000 237,429,000 253,994,000 276,711,000 328,195,000 263,601,000 220,432,000 243,784,000 276,066,000 464,751,000 432,082,000 410,901,000 437,428,000 500,559,000 857,741,000 863,624,000 830,727,000 1,123,645,000 1,183,103,000 1,442,307,000 1,567,895,000 870,540,000 1,745,225,000 1,480,470,000 349,051,000 237,021,000 224,201,000 197,177,000 174,701,000 163,053,000 140,691,000 126,563,000 133,059,000 215,572,000 210,324,000 196,725,000 191,713,000 185,158,000 198,520,000 28,585,000 33,403,000 24,881,000 16,635,000 14,570,000 17,740,000 23,823,000 17,434,000 21,096,000 23,544,000 32,230,000 26,817,000 28,139,000 31,296,000 37,019,000 35,287,000 43,402,000 50,387,000 68,166,000 59,895,000 69,470,000 67,695,000 93,929,000 85,965,000 96,112,000 101,899,000 109,943,000 115,775,000 132,183,000 427,947,000 235,557,000 64,527,000 113,903,000 112,340,000 132,967,000 117,708,000 108,542,000 131,701,000 172,824,000 118,811,000 124,902,000 105,862,000 56,973,000 63,011,000 83,753,000 48,267,000 
      intangible assets
    		233,535,000 250,133,000 258,391,000 266,648,000 274,905,000 283,162,000 291,420,000 299,606,000 314,843,000 325,377,000 333,916,000 342,455,000 517,025,000 528,364,000 539,707,000 551,040,000 562,372,000 572,006,000 583,785,000 595,330,000 224,582,000 215,295,000 206,520,000 210,448,000 216,268,000 212,609,000 216,290,000 219,793,000 216,276,000 222,001,000 225,306,000 228,584,000 196,578,000 199,284,000 201,990,000 204,705,000 207,435,000 210,142,000 212,823,000 48,347,000 48,941,000 49,535,000 50,129,000 50,723,000 51,317,000 51,911,000 52,505,000 53,099,000 53,692,000 54,245,000 55,319,000 55,912,000 56,580,000 56,273,000 56,855,000 57,437,000                                    
      goodwill
    		101,541,000 101,541,000 101,541,000 105,250,000 105,250,000 105,250,000 105,250,000 103,370,000 103,770,000 105,673,000 105,673,000 105,673,000 181,206,000 181,206,000 181,206,000 181,206,000 190,183,000 190,517,000 190,515,000 189,662,000 102,136,000 103,369,000 94,341,000 95,229,000 93,513,000 88,000,000 86,809,000 86,646,000 85,961,000 85,961,000 85,961,000 85,959,000 72,207,000 72,207,000 72,207,000 72,207,000 72,359,000 72,360,000 72,997,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 12,238,000 14,894,000 14,894,000 14,894,000                                    
      long-term portion of financial royalty assets
    		206,332,000 193,556,000 188,320,000 185,024,000 199,251,000 80,481,000 65,710,000                                                                                     
      noncurrent derivative assets
    		9,351,000 17,958,000 18,029,000 10,583,000 19,246,000 34,505,000                                                                                      
      property and equipment
    		3,466,000 3,632,000 3,623,000 15,133,000 15,094,000 14,970,000 15,135,000 15,607,000 16,178,000 11,382,000 11,743,000 12,482,000 33,418,000 30,954,000 24,584,000 20,511,000 18,702,000 17,628,000 16,896,000 14,434,000 7,157,000 7,883,000 6,690,000 7,185,000 6,411,000 6,268,000 5,575,000 5,372,000 4,407,000 4,187,000 4,119,000 4,212,000 3,526,000 1,875,000 1,898,000 1,819,000 1,826,000 1,181,000 567,000 372,000 355,000 405,000 440,000 486,000 551,000 619,000 690,000 867,000 834,000 804,000 758,000 788,000 853,000 644,000 375,000 455,000 678,000 679,000 795,000 559,000 968,000 7,073,000 7,772,000 8,522,000 9,893,000 10,459,000 11,195,000 12,903,000 1,687,000 2,024,000 2,091,000 2,865,000 3,434,000 3,783,000 4,022,000 5,551,000 21,453,000 21,561,000 21,758,000 22,483,000 22,638,000 22,927,000 23,275,000 23,647,000 23,910,000 23,620,000 9,072,000 8,843,000 9,229,000 9,672,000 10,152,000 
      lease right-of-use assets
    		7,609,000 7,991,000 6,869,000                                                                                         
      equity method investments
    		42,000,000                                                                                           
      other investments
    		106,721,000 10,908,000 10,908,000 10,908,000 11,908,000 10,741,000 36,500,000 35,726,000                                                                                    
      deferred income taxes
    		9,526,000 829,000 546,000 72,000 78,000 190,000  214,000 8,530,000 8,530,000 875,000 8,530,000 35,500,000 35,654,000 35,655,000 34,482,000 26,728,000 27,882,000 27,432,000 24,320,000 27,026,000 26,411,000 26,358,000 25,608,000    46,521,000 32,440,000 44,586,000 69,368,000 84,422,000 134,939,000 138,837,000 141,007,000 123,891,000 133,486,000 161,076,000 157,258,000 216,564,000 7,517,000 3,059,000 2,797,000  1,214,000 1,104,000 1,151,000  8,000 8,000 791,000  237,000 237,000 237,000 237,000 1,194,000 1,169,000 1,021,000  25,068,000 25,068,000 25,068,000 25,068,000                            
      other assets
    		2,771,000 9,111,000 7,892,000 6,924,000 8,404,000 11,922,000 11,225,000 5,923,000 8,426,000 4,495,000 4,634,000 4,736,000 6,279,000 6,316,000 6,442,000 2,741,000 3,095,000 2,828,000 3,053,000 4,267,000 13,704,000 6,059,000 1,270,000 2,357,000 2,488,000 1,680,000 6,396,000 471,000 499,000 642,000 894,000 4,859,000 2,028,000 1,668,000 1,821,000 1,744,000 1,744,000 603,000 70,000 27,000 248,000 301,000 358,000 207,000 230,000 253,000 275,000 299,000 344,000 394,000 451,000 517,000 416,000 524,000 563,000 738,000 777,000 773,000 883,000 838,000 5,453,000 5,494,000 5,537,000 5,081,000 101,000 101,000 101,000 144,000        36,000 1,264,000 3,665,000 4,011,000 4,704,000 5,597,000 5,928,000 6,326,000 6,174,000 8,420,000 8,822,000 11,134,000 11,718,000 12,333,000 17,992,000 22,163,000 
      total assets
    		1,476,772,000 948,604,000 905,435,000 941,774,000 954,866,000 866,405,000 913,869,000 787,216,000 769,226,000 758,105,000 811,076,000 762,668,000 1,050,605,000 1,076,288,000 1,105,184,000 1,297,590,000 1,273,656,000 1,256,283,000 1,295,121,000 1,362,285,000 1,247,449,000 1,242,936,000 1,185,917,000 1,494,915,000 1,547,476,000 1,801,836,000 1,913,988,000 1,260,803,000 2,105,742,000 1,858,284,000 754,668,000 671,021,000 662,337,000 640,024,000 629,723,000 601,585,000 600,865,000 616,799,000 613,438,000 533,929,000 521,700,000 304,762,000 263,223,000 258,029,000 272,283,000 99,847,000 105,471,000 104,713,000 101,677,000 99,571,000 98,363,000 104,260,000 97,506,000 104,594,000 111,798,000 122,350,000 122,466,000 127,435,000 134,153,000 75,559,000 112,568,000 127,597,000 133,620,000 141,807,000 117,086,000 129,176,000 139,587,000 171,448,000 147,191,000 160,023,000 166,265,000 173,278,000 211,524,000 228,476,000 524,810,000 326,053,000 231,867,000 285,932,000 288,689,000  306,047,000 301,723,000 313,253,000  285,317,000 294,189,000 272,797,000     
      liabilities and stockholders’ equity
    		                                                                                           
      current liabilities:
    		                                                                                           
      accounts payable
    		3,679,000 8,584,000 5,366,000 5,233,000 4,694,000 1,793,000 1,893,000 2,427,000 2,475,000 9,582,000 6,135,000 5,307,000 15,887,000 19,153,000 6,972,000 8,403,000 7,233,000 17,273,000 9,469,000 3,784,000 10,169,000 6,103,000 3,365,000 2,420,000 2,040,000 2,888,000 5,061,000 4,183,000 1,647,000 2,682,000 3,407,000 2,259,000 3,617,000 1,799,000 6,456,000 2,734,000 2,757,000 2,336,000 2,688,000 4,083,000 3,143,000 2,708,000 7,442,000 7,698,000 4,864,000 5,059,000 3,675,000 3,951,000 4,304,000 4,755,000 5,522,000 5,854,000 6,027,000 6,746,000 7,893,000 11,065,000 10,072,000 10,628,000 13,032,000 8,597,000 11,339,000 13,445,000 14,519,000 16,945,000 14,379,000 14,844,000 15,641,000 14,627,000 9,014,000 10,290,000 10,760,000 12,682,000 10,448,000 10,939,000 13,181,000 12,259,000 16,080,000 19,460,000 16,325,000 15,360,000 9,809,000 14,276,000 14,586,000 17,352,000 20,225,000 16,866,000 17,261,000 10,819,000 13,441,000 11,979,000 9,662,000 
      accrued liabilities
    		24,084,000 17,464,000 23,537,000 27,906,000 15,600,000 12,171,000 12,430,000 12,467,000 10,635,000 7,291,000 14,977,000 15,681,000 19,338,000 14,551,000 15,877,000 17,579,000 12,237,000 10,107,000 12,110,000 18,530,000 14,498,000 12,828,000 11,848,000 9,836,000 13,060,000 11,540,000 14,771,000 19,200,000 9,267,000 9,312,000 8,480,000 7,377,000 6,423,000 5,325,000 4,680,000 6,397,000 6,675,000 4,951,000 3,669,000 5,397,000 4,156,000 5,629,000 4,263,000 4,866,000 4,311,000 3,241,000 5,451,000 5,337,000 4,619,000 4,021,000 4,518,000 4,961,000 5,381,000 4,228,000 4,143,000 8,262,000 7,480,000 6,814,000 11,904,000 8,859,000 7,566,000 5,172,000 5,581,000 9,375,000 12,411,000 6,921,000 7,771,000 12,665,000 29,183,000 22,698,000 21,698,000 24,327,000 30,870,000 39,204,000 57,380,000 46,509,000 52,902,000 58,302,000 43,502,000 59,587,000 53,737,000 42,864,000 45,716,000 43,908,000 36,108,000     11,786,000  
      income taxes payable
    		1,284,000 305,000 1,803,000  2,108,000 2,091,000 1,138,000  1,204,000 11,387,000   9,703,000 3,782,000       674,000                                                                       
      current contingent liabilities
    		268,000 1,465,000 1,484,000 206,000 128,000 146,000 127,000 256,000   67,000 57,000 1,773,000 2,258,000 1,524,000 2,588,000 2,594,000 5,650,000 41,509,000 39,884,000 1,194,000 1,416,000 871,000 2,607,000 1,794,000 4,763,000 4,666,000 5,717,000 3,678,000 7,495,000 7,545,000 4,703,000 86,000 86,000 111,000 5,088,000 5,079,000 5,337,000 5,285,000 10,414,000 7,620,000 7,674,000 3,692,000  4,184,000                                               
      current operating lease liabilities
    		1,089,000 1,089,000 859,000 1,266,000 1,066,000 1,156,000 1,000,000 403,000 497,000 680,000 660,000 670,000 2,345,000 2,501,000 1,850,000 2,053,000 2,181,000 2,275,000 2,173,000 1,885,000                                                                        
      other current liabilities
    		135,000        916,000 448,000                           1,505,000 121,000 21,000 8,000 34,000 300,000                                                  
      total current liabilities
    		30,539,000 64,734,000 58,683,000 37,112,000 24,772,000 18,565,000 17,818,000 16,782,000 15,727,000 29,388,000 98,929,000 98,810,000 135,241,000 167,853,000 42,578,000 41,665,000 36,297,000 52,497,000 95,805,000 100,111,000 42,300,000 29,264,000 20,438,000 17,002,000 35,695,000 108,985,000 186,777,000 82,249,000 793,344,000 632,850,000 246,979,000 238,868,000 231,683,000 225,840,000 226,995,000 227,129,000 226,131,000 220,347,000 12,240,000 20,836,000 16,253,000 17,949,000 18,157,000 22,779,000 18,433,000 18,621,000 21,005,000 28,939,000 32,461,000 32,571,000 33,017,000 35,439,000 29,879,000 30,419,000 27,206,000 43,643,000 42,454,000 42,315,000 44,570,000 33,488,000 36,680,000 43,598,000 41,434,000 52,172,000 53,047,000 48,202,000 52,884,000 70,614,000 51,701,000 44,612,000 44,311,000 50,968,000 59,832,000 68,058,000 340,501,000 170,810,000 226,415,000 268,412,000 256,029,000 235,211,000 224,595,000 213,481,000 216,216,000 216,712,000 61,470,000 57,258,000 46,290,000 35,154,000 37,823,000 30,535,000 27,610,000 
      long-term deferred revenue
    		   2,246,000 2,508,000 2,696,000 3,065,000 1,444,000     5,537,000 7,428,000                 3,000,000 3,525,000         2,083,000 2,083,000 2,085,000  2,085,000                                               
      long-term contingent liabilities
    		3,569,000 4,097,000 4,026,000 3,475,000 3,863,000 4,052,000 2,888,000 2,942,000 3,515,000 3,505,000 2,776,000 3,456,000 6,855,000 6,961,000 7,448,000 8,483,000 6,782,000 9,121,000 9,548,000 9,249,000 9,604,000 10,005,000 5,811,000 6,335,000 7,995,000 8,314,000 8,955,000 6,825,000 9,053,000 8,146,000 6,376,000 9,258,000 5,196,000 3,860,000 3,035,000 2,916,000 3,933,000 4,138,000 4,022,000 3,033,000 7,589,000 11,089,000 8,213,000  12,267,000                                               
      long-term operating lease liabilities
    		4,415,000 4,629,000 3,565,000 5,815,000 6,267,000 6,415,000 5,191,000 5,755,000 5,832,000 10,991,000 11,183,000 10,336,000 34,893,000 27,088,000 16,758,000 15,494,000 11,467,000 4,771,000 6,081,000 5,643,000 3,920,000 9,181,000 9,231,000 9,970,000 9,932,000 10,489,000                                                                  
      long-term portion of 2030 convertible senior notes
    		445,493,000                                                                                           
      other long-term liabilities
    		19,912,000 14,369,000 14,248,000 30,163,000 29,874,000 29,351,000 27,780,000 27,758,000 43,670,000 21,664,000 21,861,000 21,966,000 21,949,000 21,924,000 29,188,000 30,977,000 27,129,000 28,006,000 28,722,000 30,866,000 25,320,000 26,471,000 22,340,000 22,480,000 7,979,000 7,692,000 11,681,000 951,000 986,000 1,563,000 1,135,000 723,000 695,000 915,000 915,000 687,000 408,000 398,000 446,000 297,000 643,000 734,000 780,000 770,000 737,000 728,000 699,000 695,000 690,000 673,000 966,000 1,086,000 403,000 388,000 388,000 388,000 545,000 694,000 842,000 1,689,000 15,995,000 11,213,000 15,155,000 7,968,000 12,824,000 7,987,000 9,015,000 9,041,000 6,779,000 6,661,000 6,635,000 3,432,000 2,940,000 2,788,000 2,631,000 2,475,000 2,406,000 3,002,000 3,037,000 3,105,000 3,047,000 3,101,000 3,099,000 3,122,000 2,925,000 3,516,000 3,627,000 3,638,000 3,664,000   
      total liabilities
    		526,601,000 120,075,000 109,901,000 111,335,000 113,688,000 91,207,000 107,348,000 86,303,000 101,330,000 93,213,000 164,759,000 165,183,000 234,307,000 273,923,000 311,992,000 476,431,000 461,590,000 469,766,000 549,281,000 652,760,000 549,625,000 547,933,000 524,021,000 727,683,000 696,895,000 760,383,000 834,014,000 699,889,000 1,406,222,000 1,238,471,000 257,490,000 252,374,000 237,574,000 230,615,000 230,945,000 230,732,000 230,472,000 224,883,000 221,361,000 229,538,000 229,519,000 235,709,000 230,828,000 233,621,000 229,500,000 36,761,000 40,470,000 55,100,000 56,862,000 60,303,000 67,767,000 77,775,000 76,271,000 86,142,000 92,555,000 105,360,000 111,755,000 113,764,000 120,800,000 72,064,000 113,664,000 116,597,000 123,131,000 129,719,000 118,239,000 133,091,000 141,940,000 169,468,000 132,892,000 128,657,000 129,386,000 131,818,000 172,889,000 181,899,000 455,063,000 286,356,000 470,712,000 512,089,000 500,702,000 412,693,000 402,116,000 391,768,000 394,864,000 395,438,000 237,318,000 233,818,000 210,201,000 199,875,000 203,153,000 196,594,000 37,361,000 
      commitments and contingencies
    		                                                                                           
      stockholders’ equity:
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2025 and december 31, 2024
    		                                                                                           
      common stock
    		20,000 20,000 20,000 20,000 19,000 19,000 18,000 18,000 18,000 17,000 17,000 17,000 17,000 17,000 17,000 17,000 17,000 17,000 17,000 16,000 16,000 16,000 16,000 17,000 17,000 19,000 20,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 28,000 21,000 21,000 20,000 20,000 20,000 20,000 20,000 20,000 21,000 21,000 21,000 22,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 21,000 124,000 123,000 123,000 119,000 119,000 119,000 119,000 101,000 101,000 101,000 101,000 100,000 101,000 100,000 100,000 78,000 78,000 78,000 73,000 73,000 73,000 73,000 73,000        
      additional paid-in capital
    		362,614,000 358,635,000 340,544,000 337,377,000 309,341,000 238,870,000 218,258,000 198,696,000 183,994,000 170,741,000 154,424,000 147,590,000 348,994,000 335,471,000 325,368,000 372,969,000 358,418,000 346,578,000 336,621,000 318,358,000 313,057,000 304,404,000 295,940,000 367,326,000 444,587,000 619,255,000 643,317,000 791,114,000 883,477,000 874,183,000 808,765,000 798,205,000 793,724,000 784,376,000 777,102,000 769,653,000 762,576,000 789,315,000 783,890,000 701,478,000 697,061,000 692,765,000 684,355,000 680,660,000 707,180,000 726,758,000 723,279,000 718,017,000 758,080,000 755,305,000 752,952,000 751,503,000 747,316,000 743,365,000 741,889,000 732,676,000 731,899,000 730,966,000 729,723,000 729,271,000 729,048,000 728,389,000 727,465,000 726,816,000 716,785,000 716,049,000 712,021,000 711,195,000 653,883,000 652,956,000 652,055,000 651,038,000 650,196,000 649,289,000 647,232,000 891,446,000 753,947,000 751,547,000 748,742,000 720,988,000 720,943,000 720,924,000 720,752,000 719,952,000 732,096,000 730,178,000 725,244,000 678,577,000 677,561,000 693,213,000 693,153,000 
      accumulated other comprehensive income
    		9,322,000 8,494,000                          -1,024,000 -64,000 -151,000 -286,000 2,486,000 3,335,000 3,059,000 3,105,000 2,743,000 3,652,000 3,745,000 3,568,000 4,903,000 5,558,000 11,265,000 9,334,000 4,953,000 3,543,000 5,041,000 10,943,000 2,914,000 2,201,000 1,395,000 1,166,000       0 5,000 31,000 76,000 885,000 1,021,000 513,000 317,000 94,000 11,000 81,000 103,000 -28,000 -43,000 9,000    -481,000 -138,000 30,000 1,021,000 490,000 -182,000 -420,000 -738,000 229,000      -43,000 -60,000 
      retained earnings
    		578,215,000 461,380,000 456,533,000 498,984,000 530,072,000 537,244,000 589,155,000 503,016,000 484,828,000 495,101,000 492,811,000 450,862,000 468,347,000 467,943,000 468,838,000 449,090,000 454,506,000 440,783,000 410,058,000 391,952,000 386,192,000 392,893,000 370,807,000 400,105,000 407,470,000 422,721,000 437,140,000                                                                 
      total stockholders’ equity
    		950,171,000   830,439,000    700,913,000    597,485,000    821,159,000    709,525,000    767,232,000    560,914,000    399,788,000    341,290,000            49,613,000    26,485,000  18,452,000 19,243,000 8,646,000 2,367,000 5,327,000 5,009,000 -4,849,000 -9,440,000 2,656,000 2,145,000 3,744,000    -10,365,000 1,954,000 19,021,000 24,534,000 29,115,000 26,290,000 34,232,000 57,402,000 27,352,000         47,999,000 60,371,000 62,596,000 27,057,000 38,023,000 74,015,000 80,665,000 
      total liabilities and stockholders’ equity
    		1,476,772,000   941,774,000    787,216,000    762,668,000    1,297,590,000    1,362,285,000    1,494,915,000    1,260,803,000    671,021,000    601,585,000    533,929,000    258,029,000    104,713,000    104,260,000  104,594,000 111,798,000 122,350,000 122,466,000            147,191,000 160,023,000 166,265,000                     
      assets held for sale
    		 35,228,000 29,685,000                  13,143,000                                           3,170,000                            
      liabilities and stockholders' equity
    		                                                                                           
      deferred revenue
    		 111,000 101,000 1,278,000 1,152,000 1,196,000 1,227,000 1,222,000   257,000 355,000 9,547,000 10,584,000 10,503,000 10,996,000 12,007,000 17,147,000 25,107,000 29,435,000 5,404,000 8,917,000 4,354,000 2,139,000 2,230,000 939,000 2,808,000 3,286,000 2,450,000                                        2,546,000 2,546,000 2,546,000                     
      current finance lease liabilities
    		 24,000 24,000 24,000 24,000 12,000 3,000 7,000    45,000    46,000    6,593,000                                                                        
      liabilities related to assets held for sale
    		 35,692,000 25,509,000                  10,361,000                                                                       
      stockholders' equity:
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2025 and december 31, 2024
    		                                                                                           
      total stockholders' equity
    		 828,529,000 795,534,000  841,178,000 775,198,000 806,521,000  667,896,000 664,892,000 646,317,000  816,298,000 802,365,000 793,192,000  812,066,000 786,517,000 745,840,000  697,824,000 695,003,000 661,896,000  850,581,000 1,041,453,000 1,079,974,000  699,520,000 619,813,000 481,100,000  403,166,000 385,116,000 371,830,000            65,001,000  44,815,000 39,268,000 30,596,000  21,235,000                                       
      total liabilities and stockholders' equity
    		 948,604,000 905,435,000  954,866,000 866,405,000 913,869,000  769,226,000 758,105,000 811,076,000  1,050,605,000 1,076,288,000 1,105,184,000  1,273,656,000 1,256,283,000 1,295,121,000  1,247,449,000 1,242,936,000 1,185,917,000  1,547,476,000 1,801,836,000 1,913,988,000  2,105,742,000 1,858,284,000 754,668,000  662,337,000 640,024,000 629,723,000  600,865,000 616,799,000 613,438,000  521,700,000 304,762,000 263,223,000  272,283,000 99,847,000 105,471,000  101,677,000 99,571,000 98,363,000  97,506,000                                       
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2025 and december 31, 2024
    		                                                                                           
      accumulated other comprehensive loss
    		  -1,563,000 -5,942,000 1,746,000 -935,000 -910,000 -817,000 -944,000 -967,000 -935,000 -984,000 -1,060,000 -1,066,000 -1,031,000 -917,000 -875,000 -861,000 -856,000 -801,000 -1,441,000 -2,310,000 -4,867,000 -216,000 -1,493,000 -542,000 -503,000                                              -110,000 -155,000 -140,000          -127,000 -53,000 -88,000 -46,000 -61,000   
      prepaid expenses
    		   1,934,000  1,911,000 1,237,000 1,182,000                                                                                    
      operating lease right-of-use assets
    		   6,907,000 7,157,000 7,403,000 6,028,000  6,235,000 11,392,000 11,666,000  32,108,000 24,711,000 15,783,000  12,951,000 6,500,000 7,611,000  4,269,000 9,689,000 9,630,000 10,353,000 10,280,000 10,964,000                                                                  
      finance lease right-of-use assets
    		   2,766,000 2,940,000 3,085,000 3,219,000                                                                                     
      equity method investment in primrose bio
    		    1,245,000 2,437,000 10,469,000 12,595,000 13,985,000                                                                                   
      income tax payable
    		   1,199,000                     16,571,000 47,455,000 113,997,000                                  29,399,000 29,003,000 28,378,000 28,108,000                            
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2024 and 2023
    		                                                                                           
      current derivative assets
    		    11,133,000 20,141,000                                                                                      
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2024 and december 31, 2023
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2024 and december 31, 2023
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2024 and december 31, 2023
    		                                                                                           
      commercial license and other economic rights
    		       67,291,000    10,182,000    10,110,000 10,748,000 10,638,000 10,451,000 10,979,000 10,834,000 10,606,000 10,381,000 20,090,000 35,413,000 40,008,000 31,023,000                                                                 
      operating lease assets
    		       6,062,000    10,914,000    16,542,000    6,892,000                                                                        
      finance lease assets
    		       3,393,000    4,095,000    16,207,000    15,842,000                                                                        
      2023 convertible senior notes
    		          76,790,000 76,695,000 76,600,000 114,974,000 176,540,000 320,717,000 316,889,000 315,318,000 352,313,000 442,293,000 454,973,000 449,672,000 444,432,000 638,959,000 631,533,000 624,209,000 616,987,000 609,864,000 602,839,000 595,912,000                                                              
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2023 and 2022
    		                                                                                           
      commercial license rights
    		        6,602,000 10,783,000 10,431,000  10,193,000 10,267,000 10,121,000             31,460,000 20,934,000 20,437,000 19,969,000 19,526,000 23,721,000 22,962,000 25,630,000 25,821,000 25,985,000 26,141,000 8,546,000 8,554,000 8,598,000 8,598,000 4,568,000 4,568,000 4,568,000 4,567,000 4,571,000 4,571,000 4,571,000 4,571,000                                          
      financing lease right-of-use assets
    		        3,566,000 3,762,000 3,943,000  14,444,000 15,032,000 15,620,000  16,795,000 17,383,000 17,950,000                                                                         
      equity securities in primrose bio
    		        33,097,000                                                                                   
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2023 and december 31, 2022
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2023 and december 31, 2022
    		                                                                                           
      current financing lease liabilities
    		          43,000  48,000 50,000 52,000  45,000 45,000 5,437,000                                                                         
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2023 and december 31, 2022
    		                                                                                           
      current assets of discontinued operations
    		                                                                                           
      non-current assets of discontinued operations
    		                                                                                           
      current liabilities of discontinued operations
    		                                                                                           
      non-current liabilities of discontinued operations
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2022 and 2021
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2022 and december 31, 2021
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2022 and december 31, 2021
    		                                                                                           
      income taxes liability
    		              5,800,000                                                                             
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2022 and december 31, 2021
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2021 and 2020
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2021 and december 31, 2020
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2021 and december 31, 2020
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2021 and december 31, 2020
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2020 and 2019
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at september 30, 2020 and december 31, 2019
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at june 30, 2020 and december 31, 2019
    		                                                                                           
      investment in viking
    		                      32,879,000 58,335,000 49,856,000 60,376,000 72,741,000 46,191,000 105,183,000 59,796,000 27,535,000 6,438,000 5,137,000 6,014,000 7,262,000 8,345,000    29,728,000                                                    
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at march 31, 2020 and december 31, 2019
    		                                                                                           
      derivative asset
    		                         14,313,000 18,718,000 22,576,000 509,257,000 399,409,000                                                              
      derivative liability
    		                         14,313,000 18,718,000 23,430,000 563,158,000 401,291,000                                                              
      2019 convertible senior notes
    		                         27,087,000 26,756,000 26,433,000 213,144,000 210,370,000 227,547,000 224,529,000 221,557,000 218,630,000 215,748,000 212,910,000 210,115,000 207,363,000                                                      
      preferred stock, 0.001 par value; 5,000 shares authorized; zero issued and outstanding at december 31, 2019 and 2018
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; none issued and outstanding at september 30, 2019 and december 31, 2018
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; none issued and outstanding at june 30, 2019 and december 31, 2018
    		                                                                                           
      preferred stock, 0.001 par value; 5,000 shares authorized; none issued and outstanding at march 31, 2019 and december 31, 2018
    		                                                                                           
      note receivable from viking
    		                              3,877,000 3,877,000 3,007,000 3,207,000  3,207,000    4,782,000                                                    
      equity component of currently redeemable convertible notes
    		                              16,078,000 18,859,000 21,597,000 24,293,000 26,948,000 29,563,000 32,138,000                                                       
      accumulated deficit
    		                           -229,197,000 -183,914,000 -254,240,000 -327,400,000 -400,924,000 -393,914,000 -402,340,000 -408,398,000 -431,127,000 -428,001,000 -401,165,000 -395,402,000 -402,010,000 -410,458,000 -634,997,000 -658,561,000 -659,315,000 -666,371,000 -667,650,000 -669,242,000 -671,339,000 -673,208,000 -675,173,000 -681,263,000 -682,759,000 -683,822,000 -682,654,000 -680,387,000 -681,771,000 -687,273,000 -683,380,000 -682,460,000 -691,947,000 -696,451,000 -684,608,000 -684,330,000 -681,574,000 -684,584,000 -686,387,000 -684,715,000 -679,626,000 -609,999,000 -591,874,000 -585,445,000 -581,512,000 -587,450,000 -588,698,000 -588,879,000 -862,802,000 -1,004,166,000 -989,246,000 -973,288,000 -831,059,000 -828,337,000 -822,056,000 -813,132,000 -794,660,000 -683,133,000 -668,917,000 -661,722,000 -650,633,000 -638,636,000 -618,316,000 -611,588,000 
      restricted cash
    		                            43,646,000               1,261,000                                38,814,000                
      current deferred revenue
    		                             1,700,000             67,000  114,000                                               
      current lease exit obligations
    		                                     239,000 577,000 934,000 1,300,000 1,638,000 1,999,000  2,526,000                                               
      note receivable from viking therapeutics
    		                                    3,207,000 3,207,000 4,767,000  5,547,000                                                   
      investment in viking therapeutics
    		                                    17,339,000 18,733,000 28,118,000  31,826,000 33,996,000                                                  
      total stockholders' equity attributable to ligand pharmaceuticals
    		                                    338,255,000 391,916,000 392,077,000  292,181,000 69,053,000 35,148,000                                                 
      long-term debt
    		                                      204,653,000  202,951,000 200,567,000 198,219,000  193,631,000                                139,371,000 139,463,000 140,553,000 166,745,000 166,834,000 166,919,000 167,002,000 167,089,000 167,256,000 167,328,000 155,250,000 155,250,000 155,250,000 155,250,000  
      capitalized ipo expenses, vie
    		                                          2,408,000 2,268,000                                                
      current debt issuance costs
    		                                       860,000 847,000 834,000 822,000 809,000 793,000                                               
      long-term debt issuance costs
    		                                       2,527,000 2,747,000 2,964,000 3,177,000 3,388,000 3,598,000                                               
      long-term notes payable
    		                                       205,372,000                                                    
      long-term lease exit obligations
    		                                         228,000 577,000  1,133,000                                               
      long-term deferred income taxes
    		                                                                                           
      total stockholders’ equity attributable to parent
    		                                       304,391,000    26,318,000                                                
      noncontrolling interests
    		                                          -2,753,000 -1,910,000 -1,589,000 -1,084,000                                              
      total stockholder's equity
    		                                       304,391,000    24,408,000                                                
      capitalized expenses
    		                                                                                           
      restricted investments
    		                                        600,000 600,000                       1,341,000 1,341,000 1,341,000 1,341,000 1,411,000 1,411,000 1,411,000 1,411,000 1,411,000 1,561,000 1,826,000 1,826,000 1,826,000 1,826,000 1,826,000 1,826,000 1,826,000 1,826,000 1,656,000 2,378,000 1,656,000 1,656,000 6,203,000 6,204,000 10,741,000 10,646,000 1,848,000 
      note receivable
    		                                         5,547,000                                                  
      current co-promote termination payments receivable
    		                                          88,000  523,000                                               
      restricted cash and investments
    		                                          600,000  1,261,000 1,261,000 1,341,000 1,341,000 4,968,000 4,162,000 3,933,000 2,767,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,341,000 1,462,000                            
      current deferred income taxes
    		                                          258,000  1,574,000                                               
      current note payable, vie
    		                                          348,000                                                 
      current co-promote termination liability
    		                                          88,000  523,000                                               
      current portion of co-promote termination payments receivable
    		                                           322,000  391,000 688,000 4,329,000 4,507,000 4,472,000 4,257,000 4,327,000 4,431,000 4,934,000 5,898,000 6,197,000 8,030,000 8,029,000 8,030,000 8,034,000 9,780,000 9,777,000 9,716,000 9,782,000 11,925,000 11,518,000 11,197,000 10,958,000 10,824,000 8,682,000 8,651,000 10,467,000 14,740,000 13,962,000 11,881,000                 
      long-term portion of co-promote termination payments receivable
    		                                             413,000 448,000 7,417,000 8,387,000 8,579,000 7,916,000 8,207,000 8,644,000 9,822,000 14,226,000 15,255,000 20,616,000 21,346,000 22,060,000 22,851,000 28,618,000 29,386,000 29,057,000 30,993,000 45,374,000 46,146,000 46,806,000 47,524,000 47,911,000 50,298,000 50,726,000 48,989,000 80,935,000 81,010,000 81,015,000                 
      current portion of contingent liabilities
    		                                           6,796,000  2,877,000 1,094,000 1,712,000 1,879,000 780,000 356,000 356,000 323,000                                       
      current portion of deferred income taxes
    		                                           257,000  1,574,000 1,574,000 1,574,000 1,581,000 1,581,000 8,000 1,581,000                                        
      current portion of notes payable (334 and 0 related to a vie, respectively
    		                                           334,000                                                
      current portion of co-promote termination liability
    		                                           322,000  391,000 688,000 4,329,000 4,507,000 4,472,000 4,257,000 4,327,000 4,431,000 4,934,000 5,898,000 6,197,000 8,030,000 8,029,000 8,030,000 8,034,000 9,780,000 9,777,000 9,716,000 9,782,000 11,925,000 11,518,000 11,197,000 10,958,000 10,824,000 8,682,000 8,651,000 10,467,000 14,740,000 13,962,000 13,083,000 12,179,000 47,722,000 45,046,000 42,533,000             
      current portion of lease exit obligations
    		                                           2,356,000  2,689,000 2,754,000 2,811,000 2,860,000 2,910,000 3,015,000 3,039,000 2,987,000 3,054,000 3,160,000                                     
      current portion of deferred revenue
    		                                           150,000  92,000  116,000 336,000 452,000 556,000 486,000 458,000 412,000 727,000 1,240,000  38,000 27,000   2,663,000 4,323,000 4,989,000 10,924,000 10,259,000 10,192,000 10,301,000        57,981,000 80,395,000 143,102,000 151,021,000 157,519,000 158,224,000 153,372,000 152,938,000 152,528,000 2,381,000 2,346,000 3,502,000 4,126,000  4,683,000  
      long-term portion of notes payable
    		                                           195,908,000                                                
      long-term portion of co-promote termination liability
    		                                             413,000 448,000 7,417,000 8,387,000 8,579,000 7,916,000 8,207,000 8,644,000 9,822,000 14,226,000 15,255,000 20,616,000 21,346,000 22,060,000 22,851,000 28,618,000 29,386,000 29,057,000 30,993,000 45,374,000 46,146,000 46,806,000 47,524,000 47,911,000 50,298,000 50,726,000 48,989,000 80,935,000 81,010,000 81,015,000 81,149,000 95,258,000 94,261,000 93,708,000             
      long-term portion of deferred revenue
    		                                           2,085,000  2,085,000 2,085,000 2,085,000 2,085,000 2,085,000 2,125,000 2,369,000 2,538,000 2,722,000 3,370,000 3,466,000 1,291,000 1,291,000 2,546,000 2,546,000 2,546,000 2,546,000 2,546,000 3,495,000 4,866,000 8,421,000 10,380,000 16,819,000    2,546,000 2,546,000 2,546,000 2,546,000 2,546,000 2,546,000 4,100,000 4,124,000 4,202,000 4,279,000 4,357,000 4,434,000 4,512,000 2,120,000 2,198,000 2,352,000 2,430,000 2,709,000 3,014,000  
      long-term portion of lease exit obligations
    		                                           934,000  1,587,000 2,339,000 3,071,000 3,725,000 4,305,000 5,074,000 5,963,000 6,534,000 7,355,000 7,716,000 8,367,000 9,171,000 9,861,000 10,548,000 11,118,000                                
      long-term portion of deferred income taxes
    		                                           2,792,000    1,098,000    725,000                                        
      long-term portion of contingent liabilities
    		                                           8,353,000  12,223,000 12,743,000 11,795,000 8,552,000 9,219,000 12,384,000 10,543,000 7,735,000                                       
      capitalized expenses, vie
    		                                            2,131,000                                               
      long-term co-promote termination payments receivable
    		                                                                                           
      current note payable
    		                                            337,000                                               
      long-term co-promote termination liability
    		                                                                                           
      total stockholders' equity attributable to parent
    		                                            44,372,000 64,170,000                                              
      capitalized ipo expenses, viking therapeutics, inc.
    		                                             1,094,000                                              
      current portion of note payable
    		                                             2,698,000 5,769,000 9,109,000 12,375,000 13,600,000 13,212,000 14,835,000 10,272,000 5,806,000 1,436,000                                     
      long-term portion of note payable
    		                                                 1,970,000 5,494,000 13,443,000 17,876,000 22,211,000 26,435,000 20,286,000 20,200,000 20,114,000 20,029,000                                 
      commitments and contingencies-see note
    		                                                                                           
      treasury stock
    		                                                -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,280,000 -42,225,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -42,134,000 -40,521,000 -36,446,000 -26,305,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 -911,000 
      bank line of credit
    		                                                     1,500,000 1,500,000 10,000,000 10,000,000 10,000,000 5,000,000                                 
      common stock subject to conditional redemption; 0 and 112,371 shares issued and outstanding at december 31, 2012 and 2011, respectively
    		                                                                                           
      common stock subject to conditional redemption; 0 and 112,371 shares issued and outstanding at september 30, 2012 and december 31, 2011, respectively
    		                                                                                           
      current portion of liability for contingent value rights
    		                                                     3,739,000 2,449,000 6,879,000 6,446,000 5,955,000                                  
      long-term portion of liability for contingent value rights
    		                                                     10,413,000 10,550,000 11,433,000                                    
      common stock subject to conditional redemption; 0 and 112,371 shares issued and outstanding at june 30, 2012 and december 31, 2011, respectively
    		                                                                                           
      stockholders’ equity
    		                                                                                           
      common stock subject to conditional redemption; 0 and 112,371 shares issued and outstanding at march 31, 2012 and december 31, 2011, respectively
    		                                                                                           
      income tax receivable
    		                                                         0  4,575,000                                
      accrued litigation settlement costs
    		                                                         0  1,000,000 1,000,000 1,000,000 1,000,000 1,000,000                            
      current portion of deferred gain
    		                                                        426,000 851,000 1,277,000 1,702,000 1,702,000 1,702,000 1,702,000 1,702,000 1,702,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000 1,964,000                
      current portion of lease termination payments
    		                                                         0 5,300,000 5,296,000 5,292,000 9,786,000 4,493,000 4,487,000                            
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at december 31, 2011 and 2010, respectively
    		                                                       8,344,000                                    
      goodwill and other identifiable intangible assets
    		                                                        72,237,000 75,157,000 76,757,000 12,951,000 15,833,000 15,833,000 14,458,000 2,515,000 482,000 1,659,000 2,185,000 5,375,000                        
      liability for contingent value rights
    		                                                        14,294,000 15,006,000 17,341,000                                 
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at september 30, 2011 and december 31, 2010, respectively
    		                                                        8,344,000                                   
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at june 30, 2011 and december 31, 2010, respectively
    		                                                         8,344,000                                  
      convertible preferred stock, 0.001 par value; 833,333 shares authorized; none issued
    		                                                         0                                  
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at march 31, 2011 and december 31, 2010, respectively
    		                                                          8,344,000                                 
      payable to neurogen stockholders
    		                                                               3,770,000                            
      long-term portion of deferred gain
    		                                                            426,000 851,000 1,277,000 1,702,000 2,128,000 22,310,000 22,801,000 23,292,000 23,783,000 24,274,000 24,765,000 25,256,000 25,747,000 26,238,000 26,729,000 27,220,000                
      long-term portion of lease termination payments
    		                                                              5,284,000 5,281,000                            
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at december 31, 2010 and 2009, respectively
    		                                                           8,344,000                                
      allowances for loss on returns, rebates and chargebacks related to discontinued operations
    		                                                            1,000 14,000 19,000 31,000 354,000 1,275,000 5,590,000 9,590,000                        
      current portion of equipment financing obligations
    		                                                             39,000 81,000 91,000 172,000 241,000 349,000 1,829,000 716,000 978,000 1,238,000 1,528,000 1,810,000 1,989,000 2,151,000 2,168,000 2,150,000 2,146,000 2,298,000 2,401,000 2,488,000 2,638,000 2,651,000 2,604,000 2,453,000 2,439,000 2,299,000 1,890,000 2,105,000 2,087,000 2,342,000 
      common stock subject to conditional redemption; 112,371 shares issued and outstanding at september 30, 2010 and december 31, 2009
    		                                                            8,344,000                               
      stockholders’ equity :
    		                                                                                           
      common stock subject to conditional redemption; 674,230 shares issued and outstanding at june 30, 2010 and december 31, 2009
    		                                                             8,344,000                              
      convertible preferred stock, 0.001 par value; 5,000,000 shares authorized; none issued
    		                                                                                           
      common stock subject to conditional redemption; 674,230 shares issued and outstanding at march 31, 2010 and december 31, 2009
    		                                                              8,344,000                             
      restricted indemnity account
    		                                                                  10,264,000 10,232,000 10,217,000 10,178,000 10,138,000 10,070,000 9,969,000 9,939,000 10,000,000                 
      long-term portion of equipment financing obligations
    		                                                                 25,000 54,000 2,178,000 172,000 266,000 403,000 627,000 889,000 1,259,000 1,641,000 2,156,000 2,699,000 2,851,000 3,251,000 3,430,000 3,361,000 3,910,000 4,113,000 4,003,000 3,547,000 3,518,000 2,682,000 3,403,000 3,707,000 4,095,000  
      common stock subject to conditional redemption; 674, 230 and 997,568 shares issued and outstanding at december 31, 2009 and 2008, respectively
    		                                                               8,344,000                            
      liabilities and stockholders’ deficit
    		                                                                                           
      current portion of accrued litigation settlement costs
    		                                                                1,180,000 1,180,000 180,000 8,680,000                        
      common stock subject to conditional redemption; 674,230 and 997,568 shares issued and outstanding at september 30, 2009 and december 31, 2008, respectively
    		                                                                8,344,000                           
      stockholders’ deficit:
    		                                                                                           
      total stockholders’ deficit
    		                                                                -9,497,000 -12,259,000 -14,698,000          -251,190,000 -238,502,000 -224,358,000 -110,419,000 -108,414,000 -102,390,000 -93,956,000 -75,317,000        
      revenues:
    		                                                                                           
      royalties
    		                                                                1,651,000 2,006,000 2,730,000                         
      collaborative research and development and other revenues
    		                                                                6,250,000 5,588,000 6,740,000           1,120,000 2,972,000 10,527,000 2,172,000 4,064,000 1,940,000 11,835,000        
      total revenues
    		                                                                7,901,000 7,594,000 9,470,000          36,707,000 48,447,000 50,956,000 176,608,000 44,756,000 45,799,000 36,985,000 163,512,000        
      operating costs and expenses:
    		                                                                                           
      research and development
    		                                                                9,921,000 9,470,000 10,462,000          10,468,000 13,895,000 12,218,000 56,075,000 12,911,000 14,524,000 14,735,000 65,204,000        
      general and administrative
    		                                                                2,415,000 2,831,000 6,817,000                         
      lease termination costs
    		                                                                15,235,000                           
      write-off of acquired in-process research and development.
    		                                                                 441,000                          
      total operating costs and expenses
    		                                                                27,571,000 12,742,000 17,279,000          51,772,000 59,437,000 188,057,000 203,079,000 48,271,000 52,306,000 52,755,000 200,883,000        
      accretion of deferred gain on sale leaseback
    		                                                                -20,444,000 -491,000 491,000                         
      income from operations
    		                                                                774,000 -4,657,000 -7,318,000          -15,065,000 -10,990,000 -137,101,000 -26,471,000 -3,515,000 -6,507,000 -15,770,000 -37,371,000        
      other income:
    		                                                                                           
      interest income
    		                                                                176,000 120,000 139,000          577,000 587,000 573,000 1,890,000 483,000 398,000 444,000 1,096,000        
      interest expense
    		                                                                -21,000 -42,000 -194,000          -2,547,000 -6,156,000 -6,067,000 -12,458,000 -3,172,000 -3,030,000 -3,127,000 -12,338,000        
      other
    		                                                                126,000 103,000 -109,000          66,000 619,000 383,000 699,000 -60,000 232,000 1,000 3,705,000        
      total other income
    		                                                                281,000 181,000 -164,000          -1,904,000 -4,950,000 -5,111,000 -9,869,000 -2,749,000 -2,400,000 -2,682,000 -7,537,000        
      income before income taxes
    		                                                                1,055,000 -4,476,000 -7,482,000          -16,969,000 -15,940,000 -142,212,000  -6,264,000 -8,907,000 -18,452,000         
      income tax expense
    		                                                                             -18,000 -17,000 -59,000 -17,000 -17,000 -20,000 -233,000        
      income from continuing operations
    		                                                                1,055,000 -4,476,000 -7,482,000          -16,141,000               
      discontinued operations:
    		                                                                                           
      gain on sale of avinza product line before income tax benefit
    		                                                                608,000                           
      gain on sale of oncology product line before income tax benefit
    		                                                                140,000                           
      income tax benefit on discontinued operations
    		                                                                                           
      discontinued operations
    		                                                                748,000 2,808,000 2,366,000                         
      net income:
    		                                                                1,803,000 -1,668,000                          
      basic and diluted per share amounts:
    		                                                                                           
      net income
    		                                                                20 -10 -5,116,000          -14,918,000 -15,958,000 -142,229,000 -36,399,000 -6,281,000 -8,924,000 -18,472,000 -45,141,000        
      weighted-average number of common shares - basic
    		                                                                113,006,842,000                           
      weighted-average number of common shares - diluted
    		                                                                113,139,102,000                           
      common stock subject to conditional redemption; 665,230 and 997,568 shares issued and outstanding at june 30, 2009 and december 31, 2008, respectively
    		                                                                 8,344,000                          
      income tax benefit
    		                                                                            828,000               
      gain on sale of avinza product line before income taxes
    		                                                                 2,592,000 2,131,000                         
      gain on sale of oncology product line before income taxes
    		                                                                 216,000 235,000                         
      income tax benefit (expense) on discontinued operations
    		                                                                                           
      weighted-average number of common shares
    		                                                                 113,147,714,000 113,118,073,000          78,670,137,000 78,539,820,000 77,496,969,000 74,019,501,000 74,041,204,000 74,036,753,000 73,916,470,000 73,692,987,000        
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at march 31, 2009 and december 31, 2008, respectively
    		                                                                  12,345,000                         
      income tax expense on discontinued operations
    		                                                                                           
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at december 31, 2008 and 2007, respectively
    		                                                                   12,345,000                        
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at september 30, 2008 and december 31, 2007
    		                                                                    12,345,000                       
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at june 30, 2008 and december 31, 2007
    		                                                                     12,345,000                      
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at march 31, 2008 and december 31, 2007
    		                                                                      12,345,000                     
      inventories
    		                                                                                   11,772,000 11,752,000 9,770,000 6,005,000 4,806,000 5,395,000 4,841,000 3,155,000 
      acquired technology and product rights
    		                                                                            84,990,000    150,271,000 153,773,000 144,275,000 127,443,000 132,520,000     148,546,000  
      note payable
    		                                                                                           
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at december 31, 2007 and 2006, respectively
    		                                                                       12,345,000                    
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at september 30, 2007 and december 31, 2006
    		                                                                        12,345,000                   
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at june 30, 2007 and december 31, 2006
    		                                                                         12,345,000                  
      dividend payable
    		                                                                          252,742,000                 
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at march 31, 2007 and december 31, 2006
    		                                                                          12,345,000                 
      current portion of inventories
    		                                                                           3,856,000 5,039,000 8,467,000 8,232,000 9,333,000 6,868,000 6,328,000 6,896,000         
      long-term portion of inventories
    		                                                                             5,211,000 5,486,000 5,869,000 8,007,000 8,727,000 6,020,000         
      acquired technology, product rights and royalty buy-down
    		                                                                           83,083,000  139,766,000 143,268,000 146,770,000            
      current portion of debt
    		                                                                           37,750,000                
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at december 31, 2006 and 2005, respectively
    		                                                                           12,345,000                
      current portion of assets held for sale
    		                                                                            8,055,000               
      long-term portion of assets held for sale
    		                                                                            57,807,000               
      current portion of long-term debt
    		                                                                            363,000 356,000 350,000 344,000 337,000 331,000 325,000 320,000 303,000 303,000      
      current portion of liabilities related to assets held for sale
    		                                                                            26,803,000               
      long-term portion of liabilities related to assets held for sale
    		                                                                            2,017,000               
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at september 30, 2006 and december 31, 2005
    		                                                                            12,345,000               
      product sales
    		                                                                            36,707,000 47,327,000 47,984,000 166,081,000 42,584,000 41,735,000 35,045,000 120,335,000        
      cost of products sold
    		                                                                            5,800,000 10,266,000 9,740,000 39,847,000 9,807,000 10,667,000 11,065,000 39,804,000        
      selling, general and administrative
    		                                                                            20,085,000 24,637,000 22,201,000 74,656,000 17,787,000 20,149,000 19,215,000 65,798,000        
      co-promotion
    		                                                                            11,776,000 11,073,000 10,957,000 32,501,000 7,766,000 6,966,000 7,740,000 30,077,000        
      co-promote termination charges
    		                                                                            3,643,000 -434,000 132,941,000             
      income from discontinued operations, net of income tax
    		                                                                            1,223,000               
      income from discontinued operations
    		                                                                            20               
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at june 30, 2006 and december 31, 2005
    		                                                                             12,345,000              
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at march 31, 2006 and december 31, 2005
    		                                                                              12,345,000             
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at december 31, 2005 and 2004, respectively
    		                                                                               12,345,000            
      sale of royalty rights
    		                                                                                   31,342,000        
      income before income taxes and cumulative effect of a change in accounting principle
    		                                                                               -36,340,000    -44,908,000        
      income before cumulative effect of a change in accounting principle
    		                                                                               -36,399,000    -45,141,000        
      cumulative effect of changing method of accounting for variable interest entity
    		                                                                                           
      pro forma amounts assuming the changed method of accounting for variable interest entity is applied retroactively
    		                                                                                           
      basic and diluted net income per share
    		                                                                                           
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at september 30, 2005 and december 31, 2004
    		                                                                                12,345,000           
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at june 30, 2005 and december 31, 2004
    		                                                                                 12,345,000          
      common stock subject to conditional redemption; 997,568 shares issued and outstanding at march 31, 2005 and december 31, 2004
    		                                                                                  12,345,000         
      short-term investments; 9,204 restricted at december 31, 2003
    		                                                                                   20,182,000        
      common stock subject to conditional redemption; 997,568 and 1,179,386 shares issued and outstanding at december 31, 2004 and 2003, respectively
    		                                                                                   12,345,000        
      debt conversion expense
    		                                                                                           
      aquired technology and product rights
    		                                                                                     135,189,000 140,526,000 143,194,000 145,862,000   
      accrued liabilites
    		                                                                                     35,304,000 23,228,000 18,319,000 17,640,000  6,540,000 
      current portion of defferred revenue
    		                                                                                        4,637,000  6,566,000 
      other long-term liabilites
    		                                                                                         3,700,000  
      deferred warrant expense
    		                                                                                           
      aquired technology
    		                                                                                          35,596,000 
      convertible note
    		                                                                                          2,500,000 
      long term portion of deferred revenue
    		                                                                                          3,319,000 
      long term portion of equipment financing obligations
    		                                                                                          3,732,000 
      accrued acquisition obligation
    		                                                                                          2,700,000 
      convertible subordinated debentures
    		                                                                                           
      zero coupon convertible senior notes
    		                                                                                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.